VistaGen Therapeutics Increases Its Drug Rescue Opportunities With Right-of-First-Offer Agreement With Cato BioVentures and Cato Research Feb 8, 2012
VistaGen Therapeutics and Synterys Sign Strategic Medicinal Chemistry Collaboration Agreement for Drug Rescue Dec 7, 2011
VistaGen Therapeutics Reports Identification of Cell Surface Marker That Permits High-Yield Purification of Human Pluripotent Stem Cell-Derived Cardiomyocytes Oct 25, 2011
VistaGen Therapeutics Presents Highlights of Its Human Stem Cell-Derived "Micro-Heart" Cardiotoxicity Assay at NIH Symposium on Cardiovascular Regenerative Medicine Oct 5, 2011
VistaGen Therapeutics Expands Key Stem Cell Technology Patent Estate Supporting Its Drug Rescue and Cell Therapy Programs Sep 28, 2011
VistaGen Therapeutics Reports Advances in Its Pancreatic Cell and Regenerative Medicine Programs Sep 26, 2011
VistaGen Therapeutics Provides Investor Update on Corporate Activities and Upcoming Initiatives Sep 14, 2011
